申联生物：2025年前三季度净利润约28万元

Group 1 - The core point of the article is that Shenlian Bio reported a revenue of approximately 238 million yuan for the first three quarters of 2025, representing a year-on-year decrease of 4.27% [1] - The net profit attributable to shareholders of the listed company was approximately 280,000 yuan [1] - As of the report date, Shenlian Bio's market capitalization was 4.4 billion yuan [2]